Completed PHASE2 INTERVENTIONAL NCT00000242

Carbamazepine Treatment of Cocaine Dependence - 1

Carbamazepine Treatment of Cocaine Dependence

Sponsor: Medical University of South Carolina

Conditions Cocaine-Related Disorders Substance-Related Disorders

Updated 6 times since 2017 Last updated: Apr 6, 2017 Started: Oct 1, 1992 Primary completion: Jan 25, 1997 Completion: Jan 25, 1997

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000242, this PHASE2 trial focuses on Cocaine-Related Disorders and Substance-Related Disorders and remains completed. Sponsored by Medical University of South Carolina, it has been updated 6 times since 1992, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
May 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Completed PHASE2

First recorded

Oct 1992

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charleston, United States